genedrive plc (LON:GDR – Get Free Report) shares shot up 13.9% on Wednesday . The company traded as high as GBX 2.13 ($0.03) and last traded at GBX 2.05 ($0.03). 12,457,688 shares traded hands during mid-day trading, a decline of 11% from the average session volume of 13,938,082 shares. The stock had previously closed at GBX 1.80 ($0.02).
genedrive Trading Down 9.1 %
The company has a debt-to-equity ratio of 8.57, a quick ratio of 5.52 and a current ratio of 1.63. The company’s 50-day moving average price is GBX 2.48 and its 200-day moving average price is GBX 2.98. The firm has a market capitalization of £13.95 million, a PE ratio of -64.43 and a beta of -0.04.
Insider Buying and Selling at genedrive
In other genedrive news, insider Ian David Gilham acquired 1,000,000 shares of the stock in a transaction dated Wednesday, August 14th. The stock was acquired at an average cost of GBX 3 ($0.04) per share, with a total value of £30,000 ($39,261.88). 14.75% of the stock is owned by insiders.
genedrive Company Profile
genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive system, a rapid thermocycler and signal detection system and semi- automated system used forqualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings.
Recommended Stories
- Five stocks we like better than genedrive
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- MercadoLibre Targets Double-Digit Upside with Argentina Boom
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Domino’s Pizza Stock Delivers: A Hot Buy for Growth Investors
- 3 Healthcare Dividend Stocks to Buy
- 3 Small-Cap Stocks Ready to Deliver Significant Growth
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.